Medici Intent to Use Trademark - Cancer Treatments
ChangeBridge: Trademarks - Pharmaceuticals (Class 005)
Summary
The USPTO received a trademark application for "MEDICI" (Serial No. TM98956738) filed by Medici Therapeutics on January 13, 2025. The application covers pharmaceutical preparations for the treatment of cancer, immune system disorders, and related conditions under an Intent-to-Use basis.
What changed
Medici Therapeutics filed a trademark application with the USPTO for "MEDICI" (Serial No. TM98956738) on January 13, 2025. The application covers pharmaceutical preparations for the treatment of cancer, immune system disorders, and related conditions, filed under Intent-to-Use provisions.
This is a routine trademark filing notice with no new compliance obligations or deadlines. No immediate regulatory action is required from other parties. Competitors or stakeholders in the pharmaceutical space may wish to conduct clearance searches if considering similar trademarks in Class 5.
Source document (simplified)
← USPTO Trademark Applications
MEDICI
Intent to Use TM98956738 Kind: intenttouse Mar 31, 2026
Abstract
Pharmaceutical preparations for the treatment of cancer, immune system disorders, and related conditions
Filing Date
2025-01-13
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.